Claim: U
Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile
IPCA Labs, Zydus Takeda, Mangalam Drugs & Organics and Wallace Pharma
As a global healthcare conglomerate operating in pharma, medtech and consumer healthcare Pharmaceutical companies Novartis and Rising Pharmaceuticals are taking action to support the latest clinical trials exploring hydroxychloroquine as a treatment for the coronavirus disease 2019 (COVID-19)
These two drugs are economic and easily available, and hence gained attention as a potential option for COVID-19 management
Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Hydroxychloroquine Drugs industry
Pharma API Manufacturers in India – The Indian pharmaceutical industry stands in the top five positions based on volume and value
1 How Supplied
Mangalam Drugs & Organics Limited: Mangalam Drugs & Organics Limited established in the year 1977
It is also used to prevent malaria infection in areas or regions where there is no known medicine (eg, chloroquine) resistance
The American Prospect does not endorse any of the following
The Texas pharmacy also has a special order form that lists 10 COVID-19 medications, none of which has been approved by the Food and Drug Administration to treat or prevent the disease